NUVISAN receives US$9.6m grant for a multi-target drug discovery program on novel non-hormonal contraceptive medicines

/PRNewswire/ -- NUVISAN ICB GmbH, a fully integrated contract research service provider for drug discovery and development ("NUVISAN ICB"), announced today...

Related Keywords

Germany ,United States ,France ,Berlin ,Arnoud Huisman ,Quyen Nguyen ,Nuvisan Gmbh ,Contract Research ,Development Manufacturing Organization ,Melinda Gates Foundation Seattle ,Melinda Gates Foundation ,Managing Director ,Chief Strategy Officer ,Manufacturing Organization ,Innovation Campus Berlin ,